DISEASE: Asthma with nasal polyps and aspirin intolerance
Entry
H01191 Disease
Name
Asthma with nasal polyps and aspirin intolerance
Description
Asthma is a phenotypically heterogeneous disorder with many etiologic factors and clinical characteristics. In some patients with asthma, aspirin and all nonsteroidal anti-inflammatory drugs (NSAIDs) trigger asthmatic attacks. This clinical syndrome is characterized by eosinophilic inflammation of nasal and bronchial tissue, often associated with nasal polyps. It has been reported that genetic variations in TBX21 are associated with susceptibility to asthma with nasal polyps and aspirin intolerance.
Category
Immune system disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
12 Diseases of the respiratory system
Certain lower respiratory tract diseases
CA23 Asthma
H01191 Asthma with nasal polyps and aspirin intolerance
Pathway-based classification of diseases [BR:br08402]
Cellular process
nt06535 Efferocytosis
H01191 Asthma with nasal polyps and aspirin intolerance
Akahoshi M, Obara K, Hirota T, Matsuda A, Hasegawa K, Takahashi N, Shimizu M, Nakashima K, Cheng L, Doi S, Fujiwara H, Miyatake A, Fujita K, Higashi N, Taniguchi M, Enomoto T, Mao XQ, Nakashima H, Adra CN, Nakamura Y, Tamari M, Shirakawa T
Title
Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma.